EP2750698
PHARMACEUTICAL COMPOSITION COMPRISING DESPRO36 EXENDIN-4(1-39)-LYS6 -NH2 FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.9.2012EP published:
20.4.2016EP application number:
12755853.4
EPO information:
European Patent Register
Max expiry date:
2.9.2032
Title:
PHARMACEUTICAL COMPOSITION COMPRISING DESPRO36 EXENDIN-4(1-39)-LYS6 -NH2 FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE
Timeline
Today
3.9.2012EP application
20.4.2016EP Publication
Owner
Name:
Sanofi-Aventis Deutschland GmbHAddress:
Brüningstraße 50, 65929, Frankfurt am Main, DE
Name:
University Of UlsterAddress:
Cromore Road Coleraine, County Londonderry BT52 1SA, GB
Inventor
Name:
HESS, SibylleAddress:
Frankfurt am Main, DE
Name:
HÖLSCHER, ChristianAddress:
Coleraine CountyLondonderry BT51 3LPNorthern Ireland, IE
Name:
BÖHME, AndreesAddress:
Paris, FR
Name:
MENUT, AgnesAddress:
Paris, FR
Name:
PRADIER, LaurentAddress:
Paris, FR
Name:
TAUPIN, VéroniqueAddress:
Paris, FR
Priority
Number:
11179784Date:
1.9.2011Country:
EP
Classification
Categories:
A61K 38/26, A61P 25/28